GlassScriptPhysician profile
Alfredo Camero
NPI 1881954030
$5,659.49
in general payments reported to CMS, 2019-2025
30 companies · $1,687 in 2025
The $1,687 reported for 2025 was more than what 75% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $401 · 2021: $454 · 2022: $437 · 2023: $760 · 2024: $1,591 · 2025: $1,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,026 · Education: $11.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,025.57 |
| Education | $11.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $943.74 | 2019-2025 | Linzess, Creon, Viberzi |
| Boston Scientific Corporation | $615.43 | 2022-2025 | Exalt Model D, Resolution 360 Clip, Agile Esophageal |
| Janssen Biotech, INC. | $612.63 | 2020-2025 | Tremfya, Stelara |
| Gilead Sciences, INC. | $564.78 | 2019-2025 | Epclusa, Livdelzi |
| Madrigal Pharmaceuticals | $427.82 | 2024-2025 | Rezdiffra, Resmetirom |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $423.95 | 2019-2023 | Trulance, Xifaxan |
| Ardelyx, INC. | $231.85 | 2024-2025 | Ibsrela |
| Olympus America INC. | $190.47 | 2019-2025 | Single Use Aspiration Needle Na-U200h |
| Nestle Healthcare Nutrition INC. | $171.13 | 2021-2023 | |
| Medtronic, INC. | $161.20 | 2024 | Interstim |
| Daiichi Sankyo INC. | $153.77 | 2019-2023 | Injectafer |
| Micro-Tech Endoscopy USA, INC. | $134.23 | 2020-2023 | Forceps, Blueboost |
| Shire North American Group INC | $122.60 | 2019 | |
| Aimmune Therapeutics, INC. | $111.62 | 2024-2025 | Zenpep |
| E.R. Squibb & Sons, L.L.C. | $107.82 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $104.02 | 2020-2024 | Dificid |
| Phathom Pharmaceuticals, INC. | $92.08 | 2023-2025 | Voquezna |
| Celgene Corporation | $72.42 | 2022-2024 | Zeposia |
| Pfizer INC. | $62.71 | 2024-2025 | |
| Novo Nordisk INC | $61.11 | 2025 | Wegovy |
| Redhill Biopharma INC. | $61.03 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.63 | 2025 | Eohilia, Entyvio |
| Allergan, INC. | $40.84 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $27.54 | 2024 | Dupixent |
| Ipsen Biopharmaceuticals, INC | $23.18 | 2024 | Iqirvo |
| Genzyme Corporation | $21.88 | 2025 | |
| Shionogi INC | $19.23 | 2019 | |
| Romark Laboratories, Lc | $16.44 | 2020 | |
| Evoke Pharma, INC. | $15.91 | 2022 | |
| Intercept Pharmaceuticals, INC. | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfredo Camero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.